60 Minutes is researching a story about generic drug price increases and allegations that prices went up due to price fixing. We are looking to speak confidentially with sales and marketing representatives in the generic drug industry with any knowledge of this. You can reach Ali Rawaf by...
60 Minutes is researching a story about generic drug price increases and allegations that prices went up due to price fixing. We are looking to speak confidentially with sales and marketing representatives in the generic drug industry with any knowledge of this. You can reach Ali Rawaf by...
Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will be a real threat to Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...
Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will end the monopoly of Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...
Celgene's second quarter results beat estimates and the company lifted 2018 outlook. Celgene will not be increasing the price of its products this year. https://news.alphastreet.com/celgene-q2-2018-earnings/
anonymous
Thread
alexion
allergan
celgene
donald trump
drugprice
eli lilly
gilead
novartis
pfizer
sanofi
Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...
anonymous
Thread
biotech
david ricks
donald trump
drugprice
elanco animal health
eli lilly
merck
novartis
pfizer
pharma
The latest pharma giant to bow to Trump’s pressure on drug price is Merck (MRK). The company announced on Thursday that it would lower price on at least six of its drug in the US by 10% or more.
https://news.alphastreet.com/merck-joins-pharma-giants-in-lowering-drug-prices/